Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

Pre Market Movers
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Copy Top Investors Portfolio
Crypto Technical Analysis
Chart Pattern Signal

Resources

Blog
Earnings
Partner Program

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. IDXX
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
IDXX
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

IDXX Price Prediction Next Week

Technical Analysis

Based on the Fibonacci levels and technical indicators for IDXX:

  • Current RSI (14) at 57.59 indicates neutral momentum, not showing overbearishment
  • MACD at 1.62 suggests positive momentum
  • Price is trading between Fibonacci resistance R1 ($434.57) and R2 ($440.37)
  • 20-day SMA at $422.04 and 60-day SMA at $425.27 indicate an overall sideways trend

News Analysis

Recent key developments:

  • Morgan Stanley included IDXX in their top 20 AI-driven stocks list, highlighting companies with strong pricing power that could benefit from AI adoption
  • However, Jim Cramer recently advised against buying IDXX, citing inconsistent performance
  • Q3 2024 showed weak clinical visit trends and end-market demand, leading to lowered full-year organic revenue guidance to 5.3-6%

Price Prediction for Next Week

Based on technical and news analysis:

  • Support level: $415.78 (Fibonacci S1)
  • Resistance level: $434.57 (Fibonacci R1)

Expected price movement:

  • Bearish scenario (60% probability): Price likely to test S1 at $415.78 due to:

    • Weak clinical visit trends continuing
    • Cramer's negative sentiment affecting market psychology
    • Current price near resistance level

  • Bullish scenario (40% probability): Price could reach R1 at $434.57 if:

    • AI adoption narrative gains traction
    • Market sentiment improves on broader healthcare sector
    • Technical bounce from support levels

Recommendation: SELL

  • Entry point: Current market price
  • Target: $415.78
  • Stop loss: $440.37 (R2 level)

The stock shows technical weakness and fundamental concerns about end-market demand that could pressure prices in the near term.

Technical Analysis

Based on the Fibonacci levels and technical indicators for IDXX:

  • Current RSI (14) at 57.59 indicates neutral momentum, not showing overbearishment
  • MACD at 1.62 suggests positive momentum
  • Price is trading between Fibonacci resistance R1 ($434.57) and R2 ($440.37)
  • 20-day SMA at $422.04 and 60-day SMA at $425.27 indicate an overall sideways trend

News Analysis

Recent key developments:

  • Morgan Stanley included IDXX in their top 20 AI-driven stocks list, highlighting companies with strong pricing power that could benefit from AI adoption
  • However, Jim Cramer recently advised against buying IDXX, citing inconsistent performance
  • Q3 2024 showed weak clinical visit trends and end-market demand, leading to lowered full-year organic revenue guidance to 5.3-6%

Price Prediction for Next Week

Based on technical and news analysis:

  • Support level: $415.78 (Fibonacci S1)
  • Resistance level: $434.57 (Fibonacci R1)

Expected price movement:

  • Bearish scenario (60% probability): Price likely to test S1 at $415.78 due to:

    • Weak clinical visit trends continuing
    • Cramer's negative sentiment affecting market psychology
    • Current price near resistance level

  • Bullish scenario (40% probability): Price could reach R1 at $434.57 if:

    • AI adoption narrative gains traction
    • Market sentiment improves on broader healthcare sector
    • Technical bounce from support levels

Recommendation: SELL

  • Entry point: Current market price
  • Target: $415.78
  • Stop loss: $440.37 (R2 level)

The stock shows technical weakness and fundamental concerns about end-market demand that could pressure prices in the near term.

IDXX Similar Chart Price Prediction

The price of IDXX is predicted to go up -3.8%, based on the high correlation periods with NOK. The similarity of these two price pattern on the periods is 93.41%.

stocks logo

IDXX

stocks logo

NOK

Down: -3.8%Similarity: 93.41%

IDXX Stock Forecast & Prediction For Years 2025, 2026, 2027, 2028, 2029 and 2030

Year

IDXX Price Forecast($)

Potential Return(%)

2025

417.550

-0.120

2026

490.000

17.210

2027

520.000

24.390

2028

520.000

24.390

2029

650.000

55.480

2030

600.000

43.520

What is IDXX stock price prediction 2025 ?

IDXX stock is currently trading at $417.55, with a recent downward trend of -3.31% in regular market trading. Analysts project a 2025 price target range of $435 to $575, with an average of $494.60, driven by moderate revenue growth and expanding oncology diagnostics. However, challenges like declining veterinary visits and macroeconomic pressures may limit upside potential.

What is IDXX stock price prediction 2026 ?

IDXX stock is predicted to reach $490 by 2026, driven by consistent growth in veterinary diagnostics and expanding international markets. Analysts project a 15% EPS growth in 2025, supported by strong recurring revenue and innovation in diagnostic tools. However, macroeconomic challenges and declining U.S. veterinary visits may moderate growth.

What is IDXX stock price prediction 2027 ?

IDXX stock is projected to reach approximately $520 by 2027, driven by its strong market position in veterinary diagnostics and expected growth in oncology and pet healthcare markets. The company's recurring revenue model and expansion into new segments like cancer detection support sustained growth. However, macroeconomic challenges and slower revenue growth in recent quarters may moderate the pace of recovery.

What is IDXX stock price prediction 2028 ?

IDXX stock is predicted to reach approximately $520 by 2028. This projection is based on moderate revenue growth, margin expansion, and increased adoption of diagnostic innovations like the inVue Dx analyzer, expected to contribute meaningfully post-2026. However, macroeconomic challenges and slower veterinary visit trends may limit upside potential.

What is IDXX stock price prediction 2029 ?

IDXX stock price in 2029 is projected to reach approximately $650, driven by its strong market position in veterinary diagnostics and expected growth in oncology and international markets. This estimate assumes a compound annual growth rate (CAGR) of 9% from its current price, supported by recurring revenue streams and innovation in diagnostic tools. However, macroeconomic factors and competition could influence this trajectory.

What is IDXX stock price prediction 2030 ?

IDXX stock is projected to reach approximately $600 by 2030, driven by its strong market position in veterinary diagnostics and recurring revenue model. The company's focus on innovation, such as expanding its oncology offerings, and the growing pet healthcare market are expected to sustain long-term growth. However, macroeconomic challenges and valuation concerns may moderate the pace of appreciation.

IDXX Revenue Forecast

IDXX EPS Forecast

IDXX FAQs

What is bull‘s view on IDXX?

IDXX stock is currently trading at $432. Analysts hold a moderately bullish view, with a consensus price target of $494.60, indicating a 14.4% upside. The optimism stems from strong fundamentals, including a projected EPS growth of 15.1% in 2025, despite recent challenges like declining veterinary visits and macroeconomic pressures.

What is bear's view on IDXX?

IDXX stock has a bearish outlook due to its 20.5% decline over the past year, significantly underperforming the S&P 500's 24.2% rise. Analysts have lowered price targets, with the average now at $494.60, reflecting only a 14.4% upside, while recent downgrades suggest weakening confidence. Additionally, its high valuation metrics and slowing growth in a competitive market weigh on its prospects.

What is IDXX revenue forecast for next quarter？

The market consensus for IDXX's revenue in the upcoming quarter is projected to be approximately $1.025B USD.

What is IDXX eps forecast for next quarter？

The market consensus for IDXX's eps in the upcoming quarter is projected to be approximately $3.016 USD.

IDXX VS S&P500

Unlike human healthcare, pet health services and products require cash payments-thereby bypassing the reimbursement issues and pricing pressure associated with third-party payers.

Anecdotal information from vets suggests that Idexx's well-integrated and user-friendly practice management software helps hospitals switch to and stick with Idexx's products and services.

Idexx's sales and customer support staff garner high marks for providing high-touch service to vet practices.

Ask Intellectia about IDXX

IDXX Analyst's Forecast

Jonathan Block

Stifel

Hold

Price Target

$510 → $500

Upside

+5.65%

Stifel lowered the firm's price target on Idexx Laboratories to $500 from $510 and keeps a Hold rating on the shares. The firm believes the long-term company fundamentals "remain largely intact," but believes price will inevitably need to come down looking ahead, which will put greater pressure on visits and innovation, and believes the company's latest innovation - the inVue Dx analyzer - will not contribute meaningfully to CAG diagnostic recurring revenue growth until 2026.
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2024 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
PricingPre Market MoversFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorCopy Top Investors PortfolioCrypto Technical Analysis
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free